Capstone Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Buy |
+15,372
| New | +$1.75M | ﹤0.01% | 311 |
|
|
2018
Q1 | – | Sell |
-4,166
| Closed | -$355K | – | 323 |
|
|
2017
Q4 | $355K | Buy |
+4,166
| New | +$355K | 0.01% | 247 |
|
|
2016
Q4 | – | Sell |
-3,544
| Closed | -$225K | – | 807 |
|
|
2016
Q3 | $225K | Buy |
3,544
+158
| +5% | +$10K | ﹤0.01% | 541 |
|
|
2016
Q2 | $251K | Buy |
+3,386
| New | +$251K | ﹤0.01% | 497 |
|